Covered recipient · General Payments record
ROHAN JOTWANI
Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine
General Payments · PY2021–2024
$4,409.50
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $627.70 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SPR Therapeutics, Inc | $298.75 | 3 |
| Nalu Medical, Inc. | $131.82 | 1 |
| Saluda Medical Americas, Inc. | $103.74 | 1 |
| Abbott Laboratories | $35.00 | 1 |
| ABBVIE INC. | $33.63 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $35.00 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125291906 | CMS |
| ABBVIE INC. | $20.28 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104014016 | CMS |
| ABBVIE INC. | $13.35 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104014018 | CMS |
| Nalu Medical, Inc. | $131.82 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133998213 | CMS |
| Saluda Medical Americas, Inc. | $103.74 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081877588 | CMS |
| SPR Therapeutics, Inc | $147.64 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104927043 | CMS |
| SPR Therapeutics, Inc | $11.20 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104934317 | CMS |
| SPR Therapeutics, Inc | $139.91 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104936524 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.76 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137591922 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.